Drug pricing scheme ‘must be more transparent’, says commissioning chief

By Nick Renaud-Komiya2015-08-07T11:33:00

The deal struck between the government and the pharmaceutical industry to limit the amount the NHS spends on branded drugs must become ‘more transparent’, the director of NHS Clinical Commissioners has said.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters

to HSJ

Already a subscriber? Sign into your account here